<?xml version="1.0"?>

<document>
	<title>Mucoviscidosis: total amylase activity of serum and mixed saliva in
   homozygous and heterozygous subjects.</title>

	<author>Laszlo-A.</author>
	<author>Penzes-P.</author>
	<author>Gyurkovits-K.</author>

	<source>Acta-Paediatr-Acad-Sci-Hung. 1976. 17(4). P 293-6.</source>

	<abstract>Total amylase activity of serum and mixed saliva was studied in
   homozygotes and heterozygotes for mucoviscidosis and in healthy
   subjects. Mean serum total activity was 269.0 +/- 113.7 U/l in the
   homozygotes, exceeding in nearly 50% of the cases the values given in
   the literature and those observed in the normal controls. The
   difference against the control group was significant (P less than
   0.05). Mean serum total amylase activity of heterozygotes agreed with
   the mean value for the healthy group (203.5 +/- 79.5 U/l) without a
   significant difference. Total amylase activity in the saliva of
   homozygotes (148.700 +/- 65.700  U/l) was higher than in the
   heterozygotes /118.300 +/- 74.200 U/l) of the healthy children
   (51.700 +/- 26.500 U/l). The difference between the homozygous and
   healthy groups was strongly significant (P less than 0.01), and that
   between the heterozygous group and the combined healthy children and
   adult groups was also significant (P less than 0.05). In the
   heterozygotes, salivary amylase activity was slightly elevated but
   not significantly different from the control group and did not result
   in a change in serum total amylase activity.</abstract>

	<majorsubject>AMYLASES: an</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: me</majorsubject>

	<minorsubject>ADULT</minorsubject>
	<minorsubject>AMYLASES: bl</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: bl, fg</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HETEROZYGOTE</minorsubject>
	<minorsubject>HOMOZYGOTE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>SALIVA: an</minorsubject>

	<reference>001A  CESKA M               EXPERIENTIA                     25   555 969</reference>
	<reference>001B  CESKA M               CLIN CHIM ACTA                  26   437 969</reference>
	<reference>001C  CESKA M               CLIN CHIM ACTA                  26   445 969</reference>
	<reference>002   CHERNICK WS           J PEDIATR                       65   694 964</reference>
	<reference>003   DI SANTAGNESE PA      PEDIATRICS                      22   507 958</reference>
	<reference>004   MCDOUGALL C           PEDIATRICS                       5   114 950</reference>
	<reference>005   GAUTIER E             HELV PAEDIATR ACTA              17   415 962</reference>
	<reference>006   GYURKOVITS K          ACTA PAEDIATR ACAD SCI HUNG     15    49 974</reference>
	<reference>007   HADORN B              J PEDIATR                       73    39 968</reference>
	<reference>008   KAMARYT J             Z KLIN CHEM KLIN BIOCHEM         8   564 970</reference>
	<reference>009   KLEINBAUM H           Z KINDERHEILK                   90     7 964</reference>
	<reference>010   MANDEL ID             AM J DIS CHILD                 113   431 967</reference>
	<reference>011   MAYER WB              ACTA PAEDIATR SCAND             63   389 974</reference>
	<reference>012   NICORY C              BIOCHEM J                        6   387 922</reference>
	<reference>014   ROSSITER MA           ACTA PAEDIATR SCAND             63   389 974</reference>
	<reference>015   SEARCY RL             AM J CLIN PATHOL                46   582 966</reference>
	<reference>016   SZCZEPANSKI Z         Z KINDERHEILK                  113   297 972</reference>


</document>
